AMBALAL SARABHAI ENTERPRISES
Back to Income Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹11 Cr | ₹47 Cr | ₹29 Cr | ₹14 Cr | ₹4.25 Cr |
What is the latest Consolidated Net Profit of AMBALAL SARABHAI ENTERPRISES ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹11 Cr |
Mar2023 | ₹47 Cr |
Mar2022 | ₹29 Cr |
Mar2021 | ₹14 Cr |
Mar2020 | ₹4.25 Cr |
How is Consolidated Net Profit of AMBALAL SARABHAI ENTERPRISES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹11 Cr | -75.76 | |
Mar2023 | ₹47 Cr | 60.86 | |
Mar2022 | ₹29 Cr | 108.75 | |
Mar2021 | ₹14 Cr | 230.95 | |
Mar2020 | ₹4.25 Cr | - |
Compare Consolidated Net Profit of peers of AMBALAL SARABHAI ENTERPRISES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AMBALAL SARABHAI ENTERPRISES | ₹367.1 Cr | -2.7% | -14.6% | -18.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,744.0 Cr | -4.2% | -7.7% | 24.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,209.0 Cr | -0.6% | -5.6% | 57.5% | Stock Analytics | |
CIPLA | ₹117,762.0 Cr | 3.3% | -4.8% | 6.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,705.3 Cr | -2.4% | -12.8% | 1.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,929.3 Cr | -0.3% | -2.1% | 24.5% | Stock Analytics |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AMBALAL SARABHAI ENTERPRISES | -2.7% |
-14.6% |
-18.9% |
SENSEX | 0.3% |
-1.8% |
8.6% |
You may also like the below Video Courses